SCHEMBL12082749

SCHEMBL12082749

C[C@@H]1Cc2[nH]cnc2CN1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 6/20 0.37
▸ ADRA1D P25100 1/20 0.35
▸ HTR3A P46098 2/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ADRA2B P18089 1/20 0.34
▸ ADRA2C P18825 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ HTR3E A5X5Y0 1/20 0.34
▸ HTR3B O95264 1/20 0.34
▸ HTR3D Q70Z44 1/20 0.34
▸ HTR3C Q8WXA8 1/20 0.34
▸ MEN1 O00255 1/20 0.30
▸ BLM P54132 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ MMP3 P08254 1/20 0.30
▸ MMP8 P22894 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14369951 1.00 ADRA1A (0.37) ADRA1AADRA1DHTR3AADRA2AADRA2B
SCHEMBL12082646 1.00 ADRA1A (0.37) ADRA1AADRA1DHTR3AADRA2AADRA2B
SCHEMBL24115390 0.77 ADRA1A (0.34) ADRA1AADRA1DHTR3AADRA2AADRA2B
SCHEMBL21515924 0.76 HTR3A (0.38) ADRA1AADRA1DHTR3AADRA2AADRA2B
SCHEMBL9582228 0.76 HTR3A (0.38) ADRA1AADRA1DHTR3AADRA2AADRA2B
SCHEMBL9582692 0.76 HTR3A (0.38) ADRA1AADRA1DHTR3AADRA2AADRA2B
Hydrochloric Acid SCHEMBL9582939 0.74 HTR3A (0.37) ADRA1AADRA1DHTR3AADRA2AADRA2B
SCHEMBL20295775 0.70 MAP4K4 (0.35) HTR3AADRA2AADRA2BADRA2CSLC6A4
SCHEMBL9583101 0.70 HTR3A (0.43) ADRA1AADRA1DHTR3AADRA2AADRA2B
SCHEMBL21516355 0.67 HTR3A (0.37) ADRA1AADRA1DHTR3AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8258129-B2 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-09-04 — — US disclosed
US-20090203673-A1 4-HETEROCYCLOALKYLPYRI(MI)DINES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203673-A1 4-HETEROCYCLOALKYLPYRI(MI)DINES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS CCNI, MKI67, CCNA1 ADRA1A 224/4885ADRA1D 193/4885HTR3A 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback